ISTITUTO NAZ DI GENETICA MOLEC has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GENUV INC, NEURO THERAPEUTICS AB and ADIPOGENIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Crosti Mariacristina | 11 |
#2 | Abrignani Sergio | 11 |
#3 | Moro Monica | 11 |
Publication | Filing date | Title |
---|---|---|
WO2009081254A1 | Cells belonging to the adaptive immune system that express paq isoform of tmem126b | |
WO2009034436A2 | 'hematopoietic cells that express tmcc-1' | |
WO2008093225A2 | Sub -population of hematopoietic stem cells that express the crisp-1 protein |